Exit watch, week of Sept. 29, 2008

Biovail buys Prestwick for $100M

Biovail Corp.

(NYSE: BVF) has acquired Prestwick Pharmaceuticals Inc., a Washington, D.C.-based drug company focused on central nervous system disorders, for $100 million in cash. Prestwick had raised about $120 million in total venture funding since 2002 from Atlas Venture, Pequot Ventures, Scale Venture Partners, Sofinnova Ventures, Vivo Ventures and Warburg Pincus.

Cisco acquires Jabber

Cisco Systems has agreed to acquire Jabber Inc., a Denver-based provider of presence and messaging software. No financial terms were disclosed. Jabber raised an $8.2 million venture round in 2003 from Intel Capital and an investment arm of France Telecom.

Tethys buys Lipomics

Tethys Bioscience

, an Emeryville, Calif.-based developer of multi-biomarker technology, has acquired Lipomics Technologies, a West Sacramento, Calif.-based developer of metabolite profiling technology. No financial terms were disclosed. Lipomics had raised an undisclosed amount of funding from DFJ Frontier. Thethys is also venture-backed, having raised $54 million in funding from Kleiner Perkins Caufield & Byers, Mohr Davidow Ventures, Intel Capital and DAG Ventures.